- Lentiviral vectors are essential tools in gene therapy and cell-based treatments, used to deliver genetic material into cells for long-term expression. They are widely applied in therapies targeting cancer, genetic disorders, and infectious diseases
- The demand for lentiviral vectors is significantly driven by the growing adoption of gene and cell therapies, increasing clinical trial activity, and favorable regulatory support. Their ability to stably integrate into both dividing and non-dividing cells makes them highly desirable for durable therapeutic outcomes
- North America stands out as one of the dominant regions for lentiviral vector development, driven by strong biotechnology research, supportive regulatory frameworks, and increasing investments in advanced therapies
- For instance, the U.S. leads in FDA-approved gene therapies utilizing lentiviral vectors, with numerous biotech firms and academic institutions contributing to innovation and large-scale vector production
- Globally, lentiviral vectors rank as one of the most critical delivery systems in the gene therapy landscape, playing a pivotal role in enabling next-generation treatments and personalized medicine approaches
